Response to the Letter to the Editor concerning ‘Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis’ - Ivana Stević; Slobodan M. Janković (Biotechnology & Biotechnological Equipment)